SLPI regulates the proliferation, migration, and invasion capabilities of HCC cells via apoptosis through the mitogen-activated protein kinase (MAPK) signaling pathway [22], indicating its potential as both a tumor suppressor and a biomarker for HCC prognosis and treatment [21]. The gene discussed is WNK2; the disease is neoplasm.